Tag: NGNE
-
Biotech Blockbuster? Neurogene Could Rally 132% Says JPMorgan
JPMorgan believes Neurogene could have substantial upside as it advances an experimental gene therapy for Rett syndrome.
JPMorgan believes Neurogene could have substantial upside as it advances an experimental gene therapy for Rett syndrome.